ADIM
PEN icon

Alpha DNA Investment Management’s Penumbra PEN Stock Holding History

Alpha DNA Investment Management’s Portfolio PEN Stock Details PEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,254
Closed -$776K – 210
2023
Q2 		$776K Buy
+2,254
New +$692K 0.26% 108
2021
Q2 		– Sell
-11
Closed -$2K – 484
2021
Q1 		$2K Buy
+11
New +$2.84K ﹤0.01% 575

Other funds holding PEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Alpha DNA Investment Management's PEN Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Penumbra (PEN) in Q3 2023, closing a stake of 2,254 shares — an estimated $776K sold.

Alpha DNA Investment Management first reported a position in PEN in Q1 2021 and held it in 2 quarters. The position peaked at $776K in Q2 2023. 314 funds tracked by Wall St. Rank hold PEN as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining Penumbra position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,254 Penumbra shares in Q3 2023, an estimated $776K.
  • Alpha DNA Investment Management first reported a position in Penumbra in Q1 2021 and held it in 2 quarters.
  • Alpha DNA Investment Management's Penumbra position peaked at $776K in Q2 2023.
  • 314 funds tracked by Wall St. Rank held Penumbra as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.